Edition:
India

Intrexon Corp (XON.N)

XON.N on New York Stock Exchange

17.94USD
20 Apr 2018
Change (% chg)

$-0.14 (-0.77%)
Prev Close
$18.08
Open
$18.11
Day's High
$18.27
Day's Low
$17.89
Volume
1,188,661
Avg. Vol
404,133
52-wk High
$26.96
52-wk Low
$10.26

Chart for

About

Intrexon Corporation (Intrexon) forms collaborations to create biologically-based products and processes using synthetic biology. The Company's domestic operations are in California, Florida, Maryland, and Virginia, and its primary international operations are in Belgium and Hungary. The Company designs, builds and regulates... (more)

Overall

Beta: 1.44
Market Cap(Mil.): $2,310.36
Shares Outstanding(Mil.): 120.52
Dividend: --
Yield (%): --

Financials

BRIEF-Intrexon Corp Q4 Loss Per Share $‍0.23​

* INTREXON ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

02 Mar 2018

BRIEF-OvaScience Says Provided Intrexon Corp With Written Notice Of Termination Of Exclusive Channel Collaboration Agreement, Dated Dec 18, 2013

* OVASCIENCE SAYS PROVIDED INTREXON CORP WITH WRITTEN NOTICE OF TERMINATION OF EXCLUSIVE CHANNEL COLLABORATION AGREEMENT, DATED DEC 18, 2013-SEC FILING

02 Feb 2018

BRIEF-Intrexon Prices Public Offering Of Common Stock

* SAYS PUBLIC OFFERING OF 6 MILLION SHARES PRICED AT $12.50PER SHARE Source text for Eikon: Further company coverage:

17 Jan 2018

BRIEF-Intrexon Announces Proposed Public Offering Of Common Stock

* INTREXON ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK Source text for Eikon: Further company coverage:

17 Jan 2018

BRIEF-Intrexon posts Q3 qtrly ‍net loss per share $0.33​

* Q3 earnings per share view $-0.23 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

10 Nov 2017

BRIEF-Intrexon and Arch Pharmalabs collaborate on fermentative production of an API to replace existing process sourced from animals

* Intrexon and Arch Pharmalabs collaborate on fermentative production of an API to replace existing process sourced from animals

23 Oct 2017

Earnings vs. Estimates